reference bmd Search Results


reference bmd  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute reference bmd
Reference Bmd, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reference bmd/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
reference bmd - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
bmd reference testing  (Gradientech)
90
Gradientech bmd reference testing
Bmd Reference Testing, supplied by Gradientech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bmd reference testing/product/Gradientech
Average 90 stars, based on 1 article reviews
bmd reference testing - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
reference bmd methods  (JMI Laboratories)
90
JMI Laboratories reference bmd methods
Antimicrobial susceptibility testing interpretive criteria for delafloxacin when using disk diffusion (DD) and <t> broth microdilution </t> (BMD) MIC methods against indicated bacterial species <xref ref-type= a " width="250" height="auto" />
Reference Bmd Methods, supplied by JMI Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reference bmd methods/product/JMI Laboratories
Average 90 stars, based on 1 article reviews
reference bmd methods - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
reference bmd  (Laboratory Specialists Inc)
90
Laboratory Specialists Inc reference bmd
Example picture of A. baumannii read by reference <t>BMD</t> <t>and</t> <t>ComASP</t> (red circle indicates MIC) (a) Reference BMD: Cefiderocol MIC = 64 µg/mL, (b) ComASP: Cefiderocol MIC = 128 µg/ml (MIC by CLSI read = 8 µg/mL).
Reference Bmd, supplied by Laboratory Specialists Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reference bmd/product/Laboratory Specialists Inc
Average 90 stars, based on 1 article reviews
reference bmd - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
reference bmd panels  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute reference bmd panels
Example picture of A. baumannii read by reference <t>BMD</t> <t>and</t> <t>ComASP</t> (red circle indicates MIC) (a) Reference BMD: Cefiderocol MIC = 64 µg/mL, (b) ComASP: Cefiderocol MIC = 128 µg/ml (MIC by CLSI read = 8 µg/mL).
Reference Bmd Panels, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reference bmd panels/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
reference bmd panels - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
reference bmd method  (Laboratory Specialists Inc)
90
Laboratory Specialists Inc reference bmd method
Example picture of A. baumannii read by reference <t>BMD</t> <t>and</t> <t>ComASP</t> (red circle indicates MIC) (a) Reference BMD: Cefiderocol MIC = 64 µg/mL, (b) ComASP: Cefiderocol MIC = 128 µg/ml (MIC by CLSI read = 8 µg/mL).
Reference Bmd Method, supplied by Laboratory Specialists Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reference bmd method/product/Laboratory Specialists Inc
Average 90 stars, based on 1 article reviews
reference bmd method - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
clsi reference methods for broth microdilution (bmd)  (Laboratory Specialists Inc)
90
Laboratory Specialists Inc clsi reference methods for broth microdilution (bmd)
Example picture of A. baumannii read by reference <t>BMD</t> <t>and</t> <t>ComASP</t> (red circle indicates MIC) (a) Reference BMD: Cefiderocol MIC = 64 µg/mL, (b) ComASP: Cefiderocol MIC = 128 µg/ml (MIC by CLSI read = 8 µg/mL).
Clsi Reference Methods For Broth Microdilution (Bmd), supplied by Laboratory Specialists Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clsi reference methods for broth microdilution (bmd)/product/Laboratory Specialists Inc
Average 90 stars, based on 1 article reviews
clsi reference methods for broth microdilution (bmd) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
normal bmd values  (National Reference Center for Legionella)
90
National Reference Center for Legionella normal bmd values
Example picture of A. baumannii read by reference <t>BMD</t> <t>and</t> <t>ComASP</t> (red circle indicates MIC) (a) Reference BMD: Cefiderocol MIC = 64 µg/mL, (b) ComASP: Cefiderocol MIC = 128 µg/ml (MIC by CLSI read = 8 µg/mL).
Normal Bmd Values, supplied by National Reference Center for Legionella, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal bmd values/product/National Reference Center for Legionella
Average 90 stars, based on 1 article reviews
normal bmd values - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Antimicrobial susceptibility testing interpretive criteria for delafloxacin when using disk diffusion (DD) and broth microdilution (BMD) MIC methods against indicated bacterial species <xref ref-type= a " width="100%" height="100%">

Journal: Journal of Clinical Microbiology

Article Title: Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone

doi: 10.1128/JCM.00339-18

Figure Lengend Snippet: Antimicrobial susceptibility testing interpretive criteria for delafloxacin when using disk diffusion (DD) and broth microdilution (BMD) MIC methods against indicated bacterial species a

Article Snippet: International surveillance studies (involving 5,187 U.S. isolates and 2,727 EU isolates from 22 countries) monitored delafloxacin activity by reference BMD methods ( ) during 2014 to 2016 via a central laboratory protocol (JMI Laboratories, North Liberty, IA).

Techniques: Diffusion-based Assay

Example picture of A. baumannii read by reference BMD and ComASP (red circle indicates MIC) (a) Reference BMD: Cefiderocol MIC = 64 µg/mL, (b) ComASP: Cefiderocol MIC = 128 µg/ml (MIC by CLSI read = 8 µg/mL).

Journal: Journal of Clinical Microbiology

Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution

doi: 10.1128/jcm.00926-24

Figure Lengend Snippet: Example picture of A. baumannii read by reference BMD and ComASP (red circle indicates MIC) (a) Reference BMD: Cefiderocol MIC = 64 µg/mL, (b) ComASP: Cefiderocol MIC = 128 µg/ml (MIC by CLSI read = 8 µg/mL).

Article Snippet: Laboratory Specialists, Inc., Westlake, OH, USA, performed testing of reference BMD for all clinical isolates and both reference BMD and ComASP (using the same initial inoculum) for challenge isolates ( ).

Techniques:

Summary of ComASP using 2 different reading methods compared to CLSI BMD MIC by bacterial species for combined clinical and challenge organisms (category agreement and errors based on FDA breakpoints) <xref ref-type= a , b " width="100%" height="100%">

Journal: Journal of Clinical Microbiology

Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution

doi: 10.1128/jcm.00926-24

Figure Lengend Snippet: Summary of ComASP using 2 different reading methods compared to CLSI BMD MIC by bacterial species for combined clinical and challenge organisms (category agreement and errors based on FDA breakpoints) a , b

Article Snippet: Laboratory Specialists, Inc., Westlake, OH, USA, performed testing of reference BMD for all clinical isolates and both reference BMD and ComASP (using the same initial inoculum) for challenge isolates ( ).

Techniques: Inhibition

Comparison of ComASP MIC distribution to BMD MIC distribution for 210 Enterobacterales* (combined clinical and challenge isolates; ComASP reading method; FDA/CLSI Breakpoints [indicated with red-dotted lines]).

Journal: Journal of Clinical Microbiology

Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution

doi: 10.1128/jcm.00926-24

Figure Lengend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for 210 Enterobacterales* (combined clinical and challenge isolates; ComASP reading method; FDA/CLSI Breakpoints [indicated with red-dotted lines]).

Article Snippet: Laboratory Specialists, Inc., Westlake, OH, USA, performed testing of reference BMD for all clinical isolates and both reference BMD and ComASP (using the same initial inoculum) for challenge isolates ( ).

Techniques: Comparison

Comparison of ComASP MIC distribution to BMD MIC distribution for 126 P . aeruginosa (combined clinical and challenge isolates; ComASP reading method) (a) FDA Breakpoints (indicated with red lines). (b) CLSI Breakpoints (indicated with red-dotted lines).

Journal: Journal of Clinical Microbiology

Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution

doi: 10.1128/jcm.00926-24

Figure Lengend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for 126 P . aeruginosa (combined clinical and challenge isolates; ComASP reading method) (a) FDA Breakpoints (indicated with red lines). (b) CLSI Breakpoints (indicated with red-dotted lines).

Article Snippet: Laboratory Specialists, Inc., Westlake, OH, USA, performed testing of reference BMD for all clinical isolates and both reference BMD and ComASP (using the same initial inoculum) for challenge isolates ( ).

Techniques: Comparison

Comparison of ComASP MIC distribution to BMD MIC distribution for 92 A . baumannii (combined clinical and challenge isolates; ComASP reading method) (a) FDA Breakpoints (indicated with red lines). (b) CLSI Breakpoints (indicated with red-dotted lines).

Journal: Journal of Clinical Microbiology

Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution

doi: 10.1128/jcm.00926-24

Figure Lengend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for 92 A . baumannii (combined clinical and challenge isolates; ComASP reading method) (a) FDA Breakpoints (indicated with red lines). (b) CLSI Breakpoints (indicated with red-dotted lines).

Article Snippet: Laboratory Specialists, Inc., Westlake, OH, USA, performed testing of reference BMD for all clinical isolates and both reference BMD and ComASP (using the same initial inoculum) for challenge isolates ( ).

Techniques: Comparison

Comparison of ComASP MIC distribution to BMD MIC distribution for 40 S . maltophilia (combined clinical and challenge isolates; ComASP reading method; CLSI breakpoint [indicated with red-dotted line]).

Journal: Journal of Clinical Microbiology

Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution

doi: 10.1128/jcm.00926-24

Figure Lengend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for 40 S . maltophilia (combined clinical and challenge isolates; ComASP reading method; CLSI breakpoint [indicated with red-dotted line]).

Article Snippet: Laboratory Specialists, Inc., Westlake, OH, USA, performed testing of reference BMD for all clinical isolates and both reference BMD and ComASP (using the same initial inoculum) for challenge isolates ( ).

Techniques: Comparison

Comparison of ComASP MIC distribution to BMD MIC distribution for Enterobacterales species that are not FDA clinically indicated (combined clinical and challenge isolates) (a) Consolidated Enterobacterales (non-clinically indicated species)*, CLSI Read, EA = 76.7% (b) Consolidated Enterobacterales (non-clinically indicated species)*, ComASP Read, EA = 95.3%.

Journal: Journal of Clinical Microbiology

Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution

doi: 10.1128/jcm.00926-24

Figure Lengend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for Enterobacterales species that are not FDA clinically indicated (combined clinical and challenge isolates) (a) Consolidated Enterobacterales (non-clinically indicated species)*, CLSI Read, EA = 76.7% (b) Consolidated Enterobacterales (non-clinically indicated species)*, ComASP Read, EA = 95.3%.

Article Snippet: Laboratory Specialists, Inc., Westlake, OH, USA, performed testing of reference BMD for all clinical isolates and both reference BMD and ComASP (using the same initial inoculum) for challenge isolates ( ).

Techniques: Comparison